Long-term outcome after intensive care for COVID-19: differences between men and women-a nationwide cohort study.

Zettersten E, Engerström L, Bell M, Jäderling G, Mårtensson J, Block L, Larsson E

Crit Care 25 (1) 86 [2021-02-25; online 2021-02-25]

Questions remain about long-term outcome for COVID-19 patients in general, and differences between men and women in particular given the fact that men seem to suffer a more dramatic course of the disease. We therefore analysed outcome beyond 90 days in ICU patients with COVID-19, with special focus on differences between men and women. We identified all patient ≥ 18 years with COVID-19 admitted between March 6 and June 30, 2020, in the Swedish Intensive Care Registry. Patients were followed until death or study end-point October 22, 2020. Association with patient sex and mortality, in addition to clinical variables, was estimated using Cox regression. We also performed a logistic regression model estimating factors associated with 90-day mortality. In total, 2354 patients with COVID-19 were included. Four patients were still in the ICU at study end-point. Median follow-up time was 183 days. Mortality at 90-days was 26.9%, 23.4% in women and 28.2% in men. After 90 days until end of follow-up, only 11 deaths occurred. On multivariable Cox regression analysis, male sex (HR 1.28, 95% CI 1.06-1.54) remained significantly associated with mortality even after adjustments. Additionally, age, COPD/asthma, immune deficiency, malignancy, SAPS3 and admission month were associated with mortality. The logistic regression model of 90-day mortality showed almost identical results. In this nationwide study of ICU patients with COVID-19, men were at higher risk of poor long-term outcome compared to their female counterparts. The underlying mechanisms for these differences are not fully understood and warrant further studies.

Category: Biochemistry

Category: Genomics & transcriptomics

Type: Journal article

PubMed 33632273

DOI 10.1186/s13054-021-03511-x

Crossref 10.1186/s13054-021-03511-x

pii: 10.1186/s13054-021-03511-x
pmc: PMC7906087

Publications 9.5.0